Could This New Vaccine Put an End to Cancer?
Every new research and discovery means new hope. However, we have good news about the deadliest disease of all – cancer. Yes, there is a possibility for the success from the recent mouse studies to be duplicated in human trials.
And if this happens, we might have a treatment which can finally put an end to tumors forever.
So, we couldn’t help but wonder – could this treatment be the cure we’ve been all waiting for? Read on to find out more.
Stanford University Study
Scientists at the Stanford University have made cancer “vaccine” from 2 immune boosting agents.
Those agents are an antibody which binds to tumors and CpG oligonucleotide. This vaccine can entirely remove all cancer traces in mice. These mice were genetically modified to have different types of tumors.
As a matter of fact, out of the 90 mice in this study, 87 were free of cancer right after the first treatment. The remaining 3 mice later had a recurrence, but after the 2nd treatment, they were cancer-free as well.
Incredibly, this approach actually worked for different types of cancers such as melanoma, breast, and colon. Moreover, the same method should work on any tumor which might be infiltrated by the immune system.
The oncologist and senior researcher of the study, Ronald Levy says that the combination of the 2 agents leads to the elimination of tumors in the body.
More About the Treatment
This treatment is actually a type of cancer immunotherapy that uses the immune response of the body in order to attack the cancer cells.
However, this type of approach might be tricky since our bodies make cancer cells. This means that it is not easy to make our immune cells to identify cancer cells as harmful just like they may identify an invading virus as a threat.
Therefore, most immunotherapies try to genetically engineer or train the immune cells to select cancer cells. Nevertheless, this method may be expensive.
Why Is the Vaccine Unique?
You should know that the thing which makes this vaccine one of a kind is the fact that it you may inject it directly into a specific tumor.
Moreover, this vaccine will only impact immune cells locally found in cancer itself. There is no need for genetic engineering. Therefore the treatment methodology is greatly simplified.
The vaccine targets a particular tumor, but the activated immune cells found in the same tumor at the end spread throughout the body in order to mop up any metastases.
Human Trials Are Set to Begin
According to Ronald Levy, they witnessed incredible, bodywide effects in mice such as the elimination of tumors all over their body.
The most impressive thing is that it happened right after one, targeted injection. Of course, there is a need for a human trial, before the approval of the vaccine.
But the great news is that those trials are set to start. Around 15 participants who have low-grade lymphoma will actually be the first to try out the vaccine.
At the end of the day, if this vaccine works out, it might turn out to be one of the greatest medical discoveries in history. All we need to do now is wait, and hope for the best.